NEW PRODUCT: COGNIVAID™
Moleac has just launched a new product, CognivAiD™, in Singapore!
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries to The Possible.
A growing international network
Patients taking NeuroAid yearly
Countries with Exclusive Partnership
Let’s talk about moleac with noemie & david picard
Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO.
NEUROLOGICAL ADVANCES UNVEILED: A RECAP OF MOLEAC’S SEMINAR IN ROME WITH PROXI PHARM
We are delighted to share the highlights from the recent medical scientific seminar held in Rome, Italy, from January 24 to 26, 2024.
EXPLORING NEW FRONTIERS IN DEMENTIA: INSIGHTS FROM CAIRO, EGYPT
Last weekend, our team organized a groundbreaking scientific meeting on Dementia in the vibrant city of Cairo.
UPCOMING WEBINAR ALERT: MOLEAC SUPPORTS ASAP’S CEREBRAL SMALL VESSEL DISEASE SEMINAR
Moleac is delighted to support the upcoming webinar on Cerebral Small Vessel Disease hosted by the Asian Stroke Advisory Panel (ASAP) gathering neurology experts from Asia.
SUCCESSFUL STANDALONE NEUROLOGY EVENT IN LABUAN BAJO: ADVANCEMENTS IN STROKE AND DEMENTIA MANAGEMENT
Celebrating a successful Standalone Event in Labuan Bajo with heartfelt thanks to the 20 participating neurology experts for their invaluable contributions on stroke and dementia management.